Photo Gallery

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • WJPPS: SEPTEMBER ISSUE PUBLISHED
  • SEPTEMBER 2021 Issue has been successfully launched on 1 September 2021.

Abstract

DRUGS IN THE TREATMENT OF COVID-19

Ancha Divya*, Sana Fathima, Khoday Namratha and Saleha Fatima

ABSTRACT

COVID-19 is a disease caused by a novel corona virus now referred to as severe acute respiratory syndrome corona virus 2 (SARS-CoV-2; formerly referred to as 2019-nCoV), which was first detected in Wuhan City, Hubei Province, China, during an outbreak of respiratory disease cases. Corona viruses, from peacocks to whales, refer to a family of animal-influencing viruses. They are identified by the bulbtipped spikes that extend from the surface of the virus, giving them the resemblance of a corona. In order to respond to the ongoing serious acute respiratory syndrome corona virus 2 pandemic, treatment interventions for 2019 corona virus disease are urgently needed. In the management of corona virus disease in 2019, both antiviral drugs and immunomodulators could have their role. Unfortunately, no drugs for treating infections with human corona viruses have yet been approved. Since it will take years to produce new therapies for extreme acute respiratory corona virus 2 syndrome, the main emphasis is on modifying drugs that have been accepted or are being developed for several other indications. The data and/or recommendations are divided into 4 classes: (a) anti-viral and anti-inflammatory medicinal products, (b) anti-malaria medicinal products, (c) traditional Chinese medicinal products and (d) other medicinal products.[1]

Keywords: Corona virus, respiratory disease, animal influencing virus, immunomodulators.


[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More